Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Blacksmith Brands Announces Voluntary Recall Of Four PediaCare Children’s Products

By Pharmaceutical Processing | June 1, 2010

Blacksmith Brands, Inc., in consultation with the U.S. Food and Drug Administration, is voluntarily recalling all lots of four children’s products in the PediaCare line. These products are sold exclusively in the United States. These products were manufactured for Blacksmith Brands by McNeil Consumer Healthcare, a Division of McNeil-PPC, Inc., (a Johnson & Johnson Company) at McNeil’s Fort Washington, PA plant.

The four PediaCare items involved in the recall are:

    1. PediaCare Multi-Symptom Cold 4oz. UPC # 3 0045-0556-05 9
    2. PediaCare Long Acting Cough 4oz. UPC# 3 0045-0465-04 7
    3. PediaCare Decongestant 4oz. UPC# 3 0045-0554-04 8
    4. PediaCare Allergy and Cold 4oz. UPC# 3 0045-0552-04 4

 

Blacksmith Brands initiated the recall as a precautionary step because the products were made at the McNeil Consumer Healthcare Fort Washington, PA plant that has been temporarily shut down. A recent FDA inspection at that facility found serious problems in meeting the FDA’s current good manufacturing practice requirements. The recall was not initiated as a result of any consumer reports of adverse events and no consumer complaints have been received about the safety or purity of the products.

While the recall was not initiated as a result of either any consumer reports of adverse events or complaints with respect to the PediaCare products, tiny particles have been found in other non-PediaCare products which were manufactured at the McNeil plant.

While the potential for serious medical events is remote, the company advises consumers who have purchased these recalled products to discontinue use. Blacksmith Brands is asking Retail and Wholesale customers to withdraw the four products from their shelves and warehouses and return the product to Blacksmith Brands.

Consumers with questions may contact Blacksmith Brands on Friday, May 28th 5pm – 9pm EST; Saturday-Monday 9am-5pm EST; and normal business hours thereafter at (888) 474-3099. More information is available at blacksmithbrands.com.

Any adverse events that may be related to the use of these products should be reported to the FDA’s Med Watch Program by fax at 1-800-FDA-0178 or by mail at Med Watch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787. or on the Med watch website at http:www.fda.gov/safety/medwatch/default.htm

“We’re taking this voluntary step because protecting consumers and maintaining their trust are essential to our company’s core values,” said Blacksmith Brands Chairman and CEO Peter Mann. “Our brands have a heritage that has made them the favorites of millions of families and we are the guardians of that heritage.”

To provide these valued products to consumers again as quickly as possible, Blacksmith Brands has arranged to make them at new manufacturing plants and expects to resume shipments of the recalled items in July from those new facilities.

Items not involved in this recall are PediaCare Allergy 4oz., PediaCare Gentle Vapors Plug in Units, and PediaCare Gentle Vapors refills, all of which are produced in other facilities.

Blacksmith Brands markets, sells and distributes over-the-counter drug and personal care products that for years have provided consumers with superior, dependable results.

 

Related Articles Read More >

kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
Disposable syringe and American currency on black background
PBMs increasingly under fire in drug-pricing battle
Johnson & Johnson logo
Timeline: Navigating Johnson & Johnson’s talc lawsuits and their stock performance impact
pharmaceutical industry. Production line machine conveyor with glass bottles ampoules at factory
5 core trends in drug recalls: An analysis of 2022 and Q1 2023
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE